Abiopharma

Adlai Nortye to Participate in Upcoming Investor Conferences

XOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics N.V.

XOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics N.V.

Inotiv - Inotiv, Inc. to Report Fiscal 2025 Fourth Quarter and Full Year Financial Results and Host Conference Call on Wednesday, December 3, 2025

Inotiv, Inc. to Report Fiscal 2025 Fourth Quarter and Full Year Financial Results and Host Conference Call on Wednesday, December 3, 2025

LyondellBasell announces quarterly dividend

Azenta Reports Fourth Quarter and Full Year Fiscal 2025 Results, Ended September 30, 2025

Anaptys Announces $100 Million Stock Repurchase Plan

Anaptys Initiates Litigation Against Tesaro, a GSK Subsidiary

DexCom, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - DXCM